Any beneficial effects of mycobacteria on multiple sclerosis and experimental autoimmune encephalitis may include stimulation of the sympathetic nervous system

Medical Hypotheses
Shahram ShahabiNima Hosseini Jazani

Abstract

The inhibitory effects of mycobacterial infection and mycobacterium components on multiple sclerosis (MS) and experimental autoimmune encephalitis (EAE; an animal model for MS) have been known for years. However, this effect seems like a paradox that both mycobacterial infection and MS induce type I immune responses. Some mechanisms have been proposed or even proven for this effect in different studies, but among them there is no hint of a possible role for the nervous system (NS). Regarding the close relations between sympathetic nervous system (SNS) and MS disease course, it can be hypothesized that SNS may have a role in the effects of mycobacterium on MS. SNS can be stimulated by pro-inflammatory cytokines such as TNF-alpha and IL1-beta, production of which are induced by mycobacterial infection or mycobacterium components. Although these cytokines can inhibit SNS in the site of inflammation caused by mycobacterium, they increase sympathetic tone in other places. The beneficial role of SNS in inhibiting or attenuating the course of MS and EAE has been suggested. Inhibitory effects of stimulated SNS on MS may occur via different ways such as inhibiting the production of pro-inflammatory cytokines and inducing the synthesis o...Continue Reading

References

Mar 1, 1992·Journal of Neuroimmunology·E Chelmicka-SchorrR L Wollmann
Mar 1, 1988·Journal of Neuroimmunology·E Chelmicka-SchorrB G Arnason
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·T TsuchidaW E Biddison
Oct 26, 1999·Neurology·G RistoriM Salvetti
Jul 26, 2000·Neurology·S F Hunter, D A Hafler
Jun 30, 2001·Journal of Neuroimmunology·K MakhloufS J Khoury
Oct 17, 2001·The Journal of Clinical Investigation·K W Wucherpfennig
May 15, 2002·Immunology Letters·Diane L SewellZsuzsa Fabry
Aug 15, 2002·Neurochemistry International·Douglas L FeinsteinElena Galea
May 30, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Ling CaoDavid A Lawrence
Oct 16, 2004·Journal of Korean Medical Science·Youngil I KohJe-Jung Lee
May 4, 2005·Trends in Immunology·Thomas KamradtKlaus J Erb
Jul 5, 2005·Expert Opinion on Therapeutic Targets·M Tytell, P L Hooper
Jul 23, 2005·Journal of Applied Physiology·John D JohnsonMonika Fleshner
Jul 29, 2005·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·T B FranklinR W Currie
Oct 11, 2005·Trends in Immunology·Stefan M GoldChristoph Heesen

❮ Previous
Next ❯

Citations

Sep 5, 2019·Frontiers in Neuroscience·Chunrong LiKangding Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis